The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Primary biliary cirrhosis, hyperlipidemia, and atherosclerotic risk: A systematic review
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Poupon, R., Lindor, K., Cauch-Dudek, K., Dickson, E., Poupon, R., & Heathcote, E. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70183-5 · Cited by 648
Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis
Longo, M., Crosignani, A., Battezzati, P. M., Squarcia Giussani, C., Invernizzi, P., Zuin, M., & Podda, M. (2002) · Gut · doi:10.1136/gut.51.2.265 · Cited by 190
Mahl, T. C., Shockcor, W., & Boyer, J. L. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80139-4 · Cited by 163
Hypercholesterolemia and Atherosclerosis in Primary Biliary Cirrhosis: What Is the Risk?
Crippin, J. S., Lindor, K. D., Jorgensen, R., Kottke, B. A., Harrison, J. M., Murtaugh, P. A., & Dickson, R. E. (1992) · Hepatology · doi:10.1002/hep.1840150518 · Cited by 149
Simvastatin in primary biliary cirrhosis: effects on serum lipids and distinct disease markers
Ritzel, U., Leonhardt, U., Näther, M., Schäfer, G., Armstrong, V. W., & Ramadori, G. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00006-5 · Cited by 94
Natural history of primary biliary cirrhosis
Parés, A., & Rodés, J. (2003) · Clinics in Liver Disease · doi:10.1016/s1089-3261(03)00100-4 · Cited by 89
Research works printed but not linked: 41
- Kaplan, 2005, Primary biliary cirrhosis, N Engl J Med, 353, 1261, 10.1056/NEJMra043898 · DOI · Paper page
- Corpechot, 2005, The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis, Gastroenterology, 128, 297, 10.1053/j.gastro.2004.11.009 · DOI · Paper page
- Metcalf, 1997, Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, Engl Int J Epidemiol, 26, 830, 10.1093/ije/26.4.830 · DOI · Paper page
- Boberg, 1998, Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population, Scand J Gastroenterol, 33, 99, 10.1080/00365529850166284 · DOI · Paper page
- Leuschner, 2000, Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment, Gut, 46, 121, 10.1136/gut.46.1.121 · DOI
- Leuschner, 2005, Ursodeoxycholic acid in the therapy for primary biliary cirrhosis: effects on progression and prognosis, Z Gastroenterol, 43, 1051, 10.1055/s-2005-858281 · DOI
- Gylling, 1995, Metabolism of cholesterol and low- and high-density lipoproteins in primary biliary cirrhosis: cholesterol absorption and synthesis related to lipoprotein levels and their kinetics, Hepatology, 21, 89
- Perales, 1994, Changes in the lipid profile in chronic hepatopathies, Med Clin (Barc), 102, 364
- Kosoglou, 2005, Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions, Clin Pharmacokinet, 44, 467, 10.2165/00003088-200544050-00002 · DOI · Paper page
- Chang, 2004, Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation, J Lipid Res, 45, 2116, 10.1194/jlr.M400229-JLR200 · DOI
- Manzato, 1976, Formation of lipoprotein-X. Its relationship to bile compounds, J Clin Invest, 57, 1248, 10.1172/JCI108393 · DOI
- Jahn, 1985, Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well as altered cholesterol esterification, Gastroenterology, 89, 1266, 10.1016/0016-5085(85)90642-0 · DOI
- Rosenson, 1990, Hyperviscosity syndrome in a hypercholesterolemic patient with primary biliary cirrhosis, Gastroenterology, 98, 1351, 10.1016/0016-5085(90)90356-6 · DOI
- Walli, 1984, Role of lipoprotein-X in the pathogenesis of cholestatic hypercholesterolemia. Uptake of lipoprotein-X and its effect on 3-hydroxy-3-methylglutaryl coenzyme A reductase and chylomicron remnant removal in human fibroblasts, lymphocytes, and in the rat, J Clin Invest, 74, 867, 10.1172/JCI111504 · DOI
- Edwards, 1993, Lipoprotein-X fails to inhibit hydroxymethylglutaryl coenzyme A reductase in HepG2 cells, Metabolism, 42, 807, 10.1016/0026-0495(93)90051-O · doi:10.1016/0026-0495(93)90051-o
- Baldo-Enzi, 1988, Lipoprotein pattern and plasma lipoprotein lipase activities in patients with primary biliary cirrhosis. Relationship with increase of HDL2 fraction in Lp-X-positive and Lp-X-negative subjects, Digest Dis Sci, 33, 1201, 10.1007/BF01536666 · DOI · Paper page
- Miller, 1990, Dyslipoproteinaemia of liver disease, Baillieres Clin Endocrinol Metab, 4, 807, 10.1016/S0950-351X(05)80080-1 · DOI
- Eisenberg, 1984, High density lipoprotein metabolism, J Lipid Res, 25, 1017, 10.1016/S0022-2275(20)37713-0 · DOI · Paper page
- Owen, 1984, Abnormal high density lipoproteins from patients with liver disease regulate cholesterol metabolism in cultured human skin fibroblasts, J Lipid Res, 25, 919, 10.1016/S0022-2275(20)37730-0 · DOI
- Agorastos, 1978, Lecithin-cholesterol acyltransferase and the lipoprotein abnormalities of obstructive jaundice., Clin Sci Mol Med, 54, 369
- Muller, 1974, Hypertriglyceridaemia secondary to liver disease, Eur J Clin Invest, 4, 419, 10.1111/j.1365-2362.1974.tb00415.x · doi:10.1111/j.1365-2362.1974.tb00415.x
- Hiraoka, 1993, Decrease of hepatic triglyceride lipase levels and increase of cholesteryl ester transfer protein levels in patients with primary biliary cirrhosis: relationship to abnormalities in high-density lipoprotein, Hepatology, 18, 103, 10.1002/hep.1840180117 · DOI
- Van Dam, 1997, Primary biliary cirrhosis in The Netherlands. An analysis of associated diseases, cardiovascular risk, and malignancies on the basis of mortality figures, Scand J Gastroenterol, 32, 77, 10.3109/00365529709025067 · DOI
- Ahrens, 1949, The relationship between serum lipids and skin xanthomata in 18 patients with primary biliary cirrhosis, J Clin Invest, 28, 1565, 10.1172/JCI102222 · DOI
- Kamisako, 1995, Marked improvement in cholestasis and hypercholesterolemia with simvastatin in a patient with primary biliary cirrhosis, Am J Gastroenterol, 90, 1187
- Kurihara, 1993, Experimental use of pravastatin in patients with primary biliary cirrhosis associated with hypercholesterolemia, Clin Ther, 15, 890
- Del Puppo, 2001, Cholesterol metabolism in primary biliary cirrhosis during simvastatin and UDCA administration, J Lipid Res, 42, 437, 10.1016/S0022-2275(20)31668-0 · DOI
- Anfossi, 2004, Prescription of statins to dyslipidemic patients affected by liver diseases: a subtle balance between risks and benefits, Nutr Metab Cardiovasc Dis, 14, 215, 10.1016/S0939-4753(04)80008-5 · DOI
- Ballare, 1991, Acute cholestatic hepatitis during simvastatin administration, Recent Prog Med, 82, 233
- Huchzermeyer, 1995, Lovastatin-induced acute cholestatic hepatitis, Dtsch Med Wochenschr, 120, 252, 10.1055/s-2008-1055341 · DOI
- Bottorff MB. Statin safety and drug interactions: clinical implications. Am J Cardiol 2006. · DOI · Paper page
- Levy, 2003, Management of primary biliary cirrhosis, Curr Treat Opt Gastroenterol, 6, 493, 10.1007/s11938-003-0051-4 · DOI
- Kurihara, 2000, Bezafibrate in the treatment of primary biliary cirrhosis: comparison with ursodeoxycholic acid, Am J Gastroenterol, 95, 2990, 10.1111/j.1572-0241.2000.03220.x · DOI
- Dohmen, 2004, Fenofibrate for patients with asymptomatic primary biliary cirrhosis, World J Gastroenterol, 10, 894, 10.3748/wjg.v10.i6.894 · DOI · Paper page
- Kurihara, 2002, Investigation into the efficacy of bezafibrate against primary biliary cirrhosis, with histological references from cases receiving long term monotherapy, Am J Gastroenterol, 97, 212, 10.1111/j.1572-0241.2002.05413.x · DOI
- Balan, 1994, Effect of ursodeoxycholic acid on serum lipids of patients with primary biliary cirrhosis, Mayo Clin Proc, 69, 923, 10.1016/S0025-6196(12)61815-1 · DOI · Paper page
- Roda, 1994, Influence of ursodeoxycholic acid on biliary lipids, Scand J Gastroenterol Suppl, 204, 16, 10.3109/00365529409103619 · doi:10.3109/00365529409103619
- Stiehl, 1990, Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids, Gastroenterology, 98, 424, 10.1016/0016-5085(90)90834-N · DOI
- Fromm, 1989, Bile acid–lipoprotein interactions: effects of ursodeoxycholic acid (ursodiol), Digest Dis Sci, 34, 21S, 10.1007/BF01536658 · DOI
- Salen, 1980, Effect of high and low doses of ursodeoxycholic acid on gallstone dissolution in humans, Gastroenterology, 78, 1412, 10.1016/S0016-5085(19)30493-7 · DOI
- Tint, 1986, Effect of ursodeoxycholic acid and chenodeoxycholic acid on cholesterol and bile acid metabolism, Gastroenterology, 91, 1007, 10.1016/0016-5085(86)90708-0 · DOI
Cited by
Lindor, K. D., Gershwin, E. M., Poupon, R., Kaplan, M., Bergasa, N. V., & Heathcote, J. E. (2009) · Hepatology · doi:10.1002/hep.22906 · Cited by 1,099
Lindor, K. D., Bowlus, C. L., Boyer, J., Levy, C., & Mayo, M. (2019) · Hepatology · doi:10.1002/hep.30145 · Cited by 913
Carey, E. J., Ali, A. H., & Lindor, K. D. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00154-3 · Cited by 735
Hirschfield, G. M., Mason, A., Luketic, V., Lindor, K., Gordon, S. C., Mayo, M., Kowdley, K. V., Vincent, C., Bodhenheimer, H. C., Parés, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.12.005 · Cited by 576
Mach, F., Ray, K. K., Wiklund, O., Corsini, A., Catapano, A. L., Bruckert, E., De Backer, G., Hegele, R. A., Hovingh, G. K., Jacobson, T. A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy182 · Cited by 370
Self-citation
Metadata
- Authors
- Sorokin, A., Brown, J. L., & Thompson, P. D.
- Venue
- Atherosclerosis
- Publisher
- Elsevier BV
- Published
- 2007-10
- Volume
- 194
- Issue
- 2
- Pages
- 293-299
- ISSN
- 0021-9150 (ISSN-L)
- OpenAlex
- W1978946102
- Cited by
- 167
- References
- 6
- FWCI
- 0.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Primary biliary cirrhosis, hyperlipidemia, and atherosclerotic risk: A systematic review. https://app.cochat.ai/papers/10.1016/j.atherosclerosis.2006.11.036
- The paper
- Sorokin, A., Brown, J. L., & Thompson, P. D. (2007). Primary biliary cirrhosis, hyperlipidemia, and atherosclerotic risk: A systematic review. Atherosclerosis. https://doi.org/10.1016/j.atherosclerosis.2006.11.036
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.